相似文献
1
Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2.
Ear Nose Throat J. 2021 Apr;100(2_suppl):188S-191S. doi: 10.1177/0145561320950491. Epub 2020 Aug 27.
2
Do saline water gargling and nasal irrigation confer protection against COVID-19?
Explore (NY). 2021 Mar-Apr;17(2):127-129. doi: 10.1016/j.explore.2020.09.010. Epub 2020 Oct 1.
3
Benefits and Safety of Nasal Saline Irrigations in a Pandemic-Washing COVID-19 Away.
JAMA Otolaryngol Head Neck Surg. 2020 Sep 1;146(9):787-788. doi: 10.1001/jamaoto.2020.1622.
4
Could Simultaneous Nasal and Oral Irrigation Be a Nontherapeutic Tool against SARS-CoV-2?
ACS Chem Neurosci. 2021 Jan 6;12(1):2-4. doi: 10.1021/acschemneuro.0c00740. Epub 2020 Dec 18.
5
A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions.
Drug Res (Stuttg). 2021 Jul;71(6):348-350. doi: 10.1055/a-1467-5956. Epub 2021 Apr 22.
6
Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19.
Eur J Clin Pharmacol. 2021 Sep;77(9):1275-1293. doi: 10.1007/s00228-021-03102-3. Epub 2021 Mar 27.
7
Self-protection of medical workers in ophthalmology clinic during COVID-19 epidemic.
Eur Rev Med Pharmacol Sci. 2020 May;24(9):5155-5161. doi: 10.26355/eurrev_202005_21210.
8
Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.
Auris Nasus Larynx. 2020 Oct;47(5):715-726. doi: 10.1016/j.anl.2020.07.009. Epub 2020 Jul 23.
9
Seawater nasal wash to reduce symptom duration and viral load in COVID-19 and upper respiratory tract infections: a randomized controlled multicenter trial.
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3625-3637. doi: 10.1007/s00405-024-08518-y. Epub 2024 Feb 20.
10
SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical Practice.
Acta Med Port. 2020 Sep 1;33(9):593-600. doi: 10.20344/amp.14118. Epub 2020 Jun 16.
引用本文的文献
1
Nasal Irrigations: A 360-Degree View in Clinical Practice.
Medicina (Kaunas). 2025 Aug 1;61(8):1402. doi: 10.3390/medicina61081402.
2
Double-blind randomised trial of saline solution for gargling and nasal rinsing in SARS-CoV-2 infection.
J Glob Health. 2024 Dec 30;14:05044. doi: 10.7189/jogh.14.05044.
3
Seawater nasal wash to reduce symptom duration and viral load in COVID-19 and upper respiratory tract infections: a randomized controlled multicenter trial.
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3625-3637. doi: 10.1007/s00405-024-08518-y. Epub 2024 Feb 20.
4
Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019.
J Transl Med. 2023 Nov 17;21(1):829. doi: 10.1186/s12967-023-04719-x.
5
Using nasal sprays to prevent respiratory tract infections: a qualitative study of online consumer reviews and primary care patient interviews.
BMJ Open. 2022 Jun 30;12(6):e059661. doi: 10.1136/bmjopen-2021-059661.
6
Confirmatory Virucidal Activity of Ionised Active Water S-100® on the SARS-CoV-2 Virus.
Adv Virol. 2022 Jun 17;2022:5995775. doi: 10.1155/2022/5995775. eCollection 2022.
7
Machine learning and network medicine approaches for drug repositioning for COVID-19.
Patterns (N Y). 2022 Jan 14;3(1):100396. doi: 10.1016/j.patter.2021.100396. Epub 2021 Nov 9.
8
Photodynamic disinfection and its role in controlling infectious diseases.
Photochem Photobiol Sci. 2021 Nov;20(11):1497-1545. doi: 10.1007/s43630-021-00102-1. Epub 2021 Oct 27.
9
Coating with Hypertonic Saline Improves Virus Protection of Filtering Facepiece Manyfold-Benefit of Salt Impregnation in Times of Pandemic.
Int J Environ Res Public Health. 2021 Jul 11;18(14):7406. doi: 10.3390/ijerph18147406.
本文引用的文献
1
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
In Vivo. 2020 Jun;34(3 Suppl):1567-1588. doi: 10.21873/invivo.11946.
2
Povidone iodine.
Br Dent J. 2020 May;228(9):656-657. doi: 10.1038/s41415-020-1589-4.
3
COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.
J Clin Med. 2020 Apr 15;9(4):1126. doi: 10.3390/jcm9041126.
4
Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as "Personal Protective Equipment" for frontline providers exposed in high-risk head and neck and skull base oncology care.
Oral Oncol. 2020 Jun;105:104724. doi: 10.1016/j.oraloncology.2020.104724. Epub 2020 Apr 16.
5
Saline nasal irrigation for acute upper respiratory tract infections in infants and children: A systematic review and meta-analysis.
Paediatr Respir Rev. 2020 Nov;36:151-158. doi: 10.1016/j.prrv.2019.11.003. Epub 2020 Feb 21.
6
Catalytic inactivation of SARS coronavirus, and yeast on solid surface.
Catal Commun. 2004 Mar;5(3):170-172. doi: 10.1016/j.catcom.2003.12.009. Epub 2004 Feb 3.
7
SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection.
ACS Chem Neurosci. 2020 May 6;11(9):1200-1203. doi: 10.1021/acschemneuro.0c00172. Epub 2020 Apr 13.
8
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
Zotero 插件